DHR
38
3
ESS
64
4
PWR
72
2
ROK
47
-8
MRK
27
5
RHI
57
3
FRT
45
6
BRK.B
42
2
AAL
53
-4
IPG
53
4
BA
49
-3
HSIC
51
-3
CI
52
7
PPL
59
5
JWN
42
2
CTAS
59
4
LRCX
45
6
IVZ
48
2
MAR
65
2
CMG
67
3
DHR
38
3
ESS
64
4
PWR
72
2
ROK
47
-8
MRK
27
5
RHI
57
3
FRT
45
6
BRK.B
42
2
AAL
53
-4
IPG
53
4
BA
49
-3
HSIC
51
-3
CI
52
7
PPL
59
5
JWN
42
2
CTAS
59
4
LRCX
45
6
IVZ
48
2
MAR
65
2
CMG
67
3
Financhill
Back

Immunovant Vs. Perspective Therapeutics Industry Stock Comparison

Buy
54

IMVT
Immunovant

Last Price:
26.54
Seasonality Move:
2.57%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Buy
54
Immunovant (IMVT) is a Buy

Is Immunovant a Buy, Sell or Hold?

  • The current Immunovant [IMVT] share price is $26.54. The Score for IMVT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IMVT Stock Price Chart

What is Immunovant's stock price today?

  • The Immunovant share price today is $26.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

IMVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.94 Sell
Relative Strength Index (14 RSI): 38.78 Sell
Chaikin Money Flow: 293284 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.39 - 30.77) Sell
Bollinger Bands (100): (27.83 - 31.01) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

IMVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.04 Sell
20-day SMA: 28.9 Sell
50-day SMA: 29.13 Sell
200-day SMA: 29.97 Sell
8-day EMA: 27.04 Sell
20-day EMA: 28.26 Sell
50-day EMA: 29.02 Sell
200-day EMA: 29.56 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

Immunovant Earnings Growth & IMVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $1.15 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Immunovant Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):